Teva launches generic Bicalutamide
25th July 2008
Teva UK Limited has scored another win with the first-to-market UK launch of generic Bicalutamide tablets.
“We’re delighted to be adding this important new product to our ever-expanding generics range,” said Kim Innes, Director Teva Generics. “We have a track record in being first to market with new generic launches, including Alendronic Acid, the generic equivalent of Fosamax®. Bicalutamide is a significant addition to our portfolio and its addition to our range further consolidates our position as the UK’s leading generic supplier,” she explained.
The generic version of Casodex® from AstraZeneca, Bicalutamide from Teva is available immediately in the Teva 360 livery in the following strengths:
• Bicalutamide 50mg tablets in packs of 28
• Bicalutamide 150mg tablets in packs of 28
The Teva retail price is £104.96 for the 50mg tablets and £196.80 for the 150mg tablets.
- ends -
Contact Philippa Ward for more information
Email: media.enquiries@tevauk.com
Phone: 0113 238 0099